|
Sep 25
|
CENTOGENE Data on Novel Genetic Risk Factor for Parkinson’s Disease in The Lancet Neurology
|
|
Aug 19
|
Genetic testing in Parkinson’s disease patients: a standard of care imperative?
|
|
Jun 20
|
C-Path and CENTOGENE MOU to Enhance Collaboration in Lysosomal Disease Research and Drug Development
|
|
Jan 25
|
CENTOGENE and the Laboratory of Human Genetics of Infectious Diseases at Institut Imagine Announce Rare Disease Research Collaboration
|
|
Jan 24
|
CENTOGENE Receives French Research Tax Credit Accreditation
|
|
Dec 19
|
CENTOGENE Announces Voting Results of Extraordinary General Meeting
|
|
Nov 28
|
CENTOGENE and Lifera, a Public Investment Fund (PIF) Company, Complete Strategic Joint Venture Transaction
|
|
Nov 14
|
CENTOGENE, University College London, and Global Team of Researchers Discover Gene Associated With New Neurodevelopmental Disease Linked to Early-Onset Dystonia and Parkinsonism
|
|
Jul 14
|
CENTOGENE Regains Compliance With Nasdaq Listing Requirements
|
|
Jul 12
|
CENTOGENE Biodatabank Reveals Unique Genetic Variants in World's Largest Niemann-Pick Type C1 Disease Cohort
|
|
Apr 28
|
CENTOGENE Receives Nasdaq Non-Compliance Notice
|
|
Apr 26
|
Why Are Centogene Shares Trading Higher Today?
|
|
Apr 26
|
CENTOGENE Accelerates Global Genetic Data Interpretation, Launching FilterTool Application as Accessory to CentoCloud® Bioinformatics Pipeline
|